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blinded to presence of MS. Associations were assessed by logistic regression. 
Results: The study included 3,528 subjects; 67% were male; age averaged 63+12 years; 
57.7% had significant (270% stenosis), 11 .l% mild/moderate, and 31 .O% no CAD (~10% 
stenosis). MS was present in 48% of patients; specifically, 39% had high FG; 52% high 
TG; 71% low HDL; 76% high S/DBP; and 58% high BMI. MS predicted increased risk of 
significant CAD (odds ratio [OR] of significant vs. no CAD= 1.40, 95% Cl 1.21-1.62, 
p<O.OOl). High FG (OR=l.91, Cl 1.63223, p<O.OOl) and low HDL (O&1.38. Cl 1.18- 
1.62, pcO.OOl), but not TG, BP, or BMI, were individually predictive of CAD. In multivari- 
able modeling, CAD was predicted by age, gender, high FG (OtXl.75, Cl 1.48-2.06), 
and low HDL (O&1.45, Cl 1.22-1.72)(all p<O.OOl). Similar results (with somewhat 
greater OR for FG, HDL) were found when restricting analysis to younger subjects 
(malesc55 years, females ~65 years). 
Conclusion: In a large, prospective observational study, the MS was predictive of CAD, 
and PV was carried by high FG and low HDL. FG and HDL deserve particular attention in 
risk factor assessment and prevention in subjects at risk for CAD. 
channel. KA~p channel is also located in pancreas 0 cells. K,,, channel in pancreas 8 
cells is closed by glucose and regulates insulin release. 
Purpose. This study was undertaken to assess the interaction between acute hypergly- 
cemia and ischemic preconditioning in patients with AMIMethods. We studied 549 
patients with a first anterior wall AMI who underwent coronary angiography within 12 
hours after the onset of AMI. Acute hyperglycemia was considered to be present if 
patients had plasma glucose21 1 .l mmolJL (200 mgldl) on hospital admission. Prodromal 
angina was defined as angina episode(s) occurring within 24 hours before the onset of 
AMI. Serial measurements of left ventricular ejection fraction (LVEF) were obtained in 
434 patients (79%) before reperfusion therapy and before discharge. 
Aesulb. In 377 patients without acute hyperglycemia, prodromal angina was associated 
with significantly larger Improvement of LVEF (10.1*13.6% vs 5.9+13.3%, p=O.O15) and 
lower 30.day mortality (0% (95% Cl O-3.0) vs 6.7% (4.2-10.5). p=O.OOl). However, in the 
presence of acute hyperglycemia (n=172), there was no significant difference in the 
change in LVEF (5.6+9.9% vs 5.4+13.3%, p=O.94) and 30.day mortality (8.1% (95% Cl 
3.5-17.5) vs 8.2% (4.4-14.8), pEO.98) between patients with prodromal angina and 
patients without. Multivariate analysts showed that prodromal anglna was an mdepen- 
dent predictor of predischarge LVEF in patients without acute hyperglycemia (p=O.O19) 
and not in patients with acute hyperglycemia (p=O.96). 
Conclusion Acute hyperglycemia abolished ischemic preconditionmg effect of prodro- 
mal angina. Our findings may provide a potentlal explanation for the adverse outcome of 
patients with AMI and acute hyperglycemia. 
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1050-l 05 The Medicine, Angioplasty, or Surgery Study (MASS II 
Registry): A Comparison of Diabetic and Nondiabetic 
Patient’s Outcome in Medical Therapy, Coronary 
Angioplasty, and Bypass Surgery During the First Year 
Follow-Up 
Paula R. Soares, Whady Hueb, Bernard J. Gersh, Desiderio Favarato, Luiz M. Cesar. 
Protasio L. Luz. Seraio A. Oliveira. Jose F. Ramires, Heart Institute Medical School 
University of Sao P&lo. Sao Paula, Brazil, Mayo Clinic, Rochester, MN 
Diabetes is known to have a worse prognosis among patients with coronary artery dis- 
ease. In MASS II Registry we compared medical treatment (MT), surgety (CABG) and 
angioplasty (PCI) in patients with multivessel coronary disease. The present study com- 
pared the one-year outcome of the patients divided in two subgroups: diabetic (D) and 
non-diabetic (ND) patients in each of the therapeutic options. 1080 patients were treated 
with CABG (451), PCI (305) and MT (324). The primaly end point was considering as the 
composite events (CE) of cardiac-related deaths, myocardial infarction (Ml) and new 
revascularization (NR) in the first year of follow-up. The results are presented in the table 
1. 
Conclusion: In MASS II Registry during the first year follow-up study there were no statis- 
tical differences in the frequency of composite events between diabetic and non-diabetic 
patients in each of the three therapeutic groups. On the other hand, when outcomes 
were compared among patients undergoing PCI, CABG or MT, there was a statistically 




N Death% Ml % NR % CE % 
D 75 5.3 2.7 8.0 16.0 
ND 230 2.6 6.5 10.9 20.0 
Total 305 3.3 5.6 10.2 19.0 
CABG D 154 3.9 0.6 0.0 4.5’ 
ND 297 2.7 1.0 0.3 4.0 
Total 451 3.1 0.9 0.2 4.2 
MT D 115 5.2 1.7 6.1 13.0 
ND 209 1.4 1.9 5.7 9.1 
Total 324 2.8 1.9 5.9 10.5 
*CABG “s MT “s PCI, p=O.O028 
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1068A-MP-204 Impact of Diabetes on Clinical, Echocardiographic, and 
Electrocardiographic Characteristics of Myocardial 
Infarction 
Costantlna Manes Marc A. Pfeffer. John D. Rutherford, Sally Greaves, Jean-Lucien 
Rouleau, Scott D. Solomon, BrIgham &Women’s Hospital, Boston, MA 
Background Diabetes mfluences the clinical presentation and course of acute myocar- 
dial infarction (AMI). We investigated the Impact of diabetes on clinical, echocardlo- 
graphic and electrocardiographic characteristics of 272 pts with Q-wave anterior AMI 
enrolled in the Healing and Early Afterload Reducing Therapy (HEART) Trial Methods: 
Patients underwent ECG testing within 24h (baseline) and at predischarge (median day 
7) after AMI, and echocardiography at baseline and at 14 days. From both ECGs we cal- 
culated the Selvester CIRS score, the sum of ST segment elevation and the number of 
neaative T waves in leads I, avL. VI-V6. Left ventricular eiection fraction ILVEF) and inf- 
arct segment length were assessed by echocardiography. Results: Diabetics (n=56, 
20.6%) were similar to non-diabetics (n=216. 79.4%) with resoect to initial and 14-dav 
Infarct size es evidenced by maximal CK, ejection fraction and infarct segment length 
(Table). However, diabetics demonstrated a higher Killip class, greater QRS score at 
baseline and predlscharge and fewer negative T waves on predischarge ECG, even after 
excluding patients with prior myocardial infarction (n=43, 16%). Conclusion: Diabetes 
may modify the clinical and electrocardiographic response to myocardial infarction inde- 
pendently of infarct size or ventricular function. 
Age, yr 
Killip Class >I, % 
Maximal CK, mU/mL 
Baseline LVEF. % 
Baseline Infarct Seyment Length, % 
Day 14 LVEF, % 
Day 14 Infarct Segment Length, % 
Baseline Sum ST Elevation, mm 
Diabetics Non-Diabetics P 
(n=56) (n=216) VSIUS 
60.8 * 10.9 59.6 * 13.1 0.5 
34% 19% 0.01 
2593 * 1887 2484 f 2012 0.71 
51.6 * 10.1 52.2 f. 9.4 0.67 
27.2 * 9.8 25.8 f 11 .O 0.36 
54.5 * 10.3 56.5 * 8.9 0.14 
20.6 * 12.2 17.9 * 13.0 0.16 
11.5 * 9.2 10.5 * 7.9 0.44 
Baseline Number Negative T waves 0.7 f 1.4 0.8 f 3.2 0.85 
1068A-MP Moderated Poster Baseline QRS Score 4.3 * 2.9 3.4 * 2.6 0.03 
Session...Hyperglycemia and Diabetes in Predischarge Sum ST Elevation, mm 4.5 f 3.0 4.6 f 3.3 0.9 
Acute Coronary Syndromes II Predischarge Number Negative T 1.4* 1.7 2.6 * 2 2 0.001 
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1068A-MP-203Acute Hyperglycemia Abolishes lschemic 
Preconditioning: A Possible Mechanism for Adverse 
Outcome of Patients With Acute Myocardial Infarction 
and Acute Hyperglycemia 
Masaharu Ishihara, lchiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Kenji 
Nishioka. Takashi Umemura, Shuji Nakamura, Masashi Yoshida, Hiroshima City 
Hospital, Hiroshima, Japan 
Background. Acute hyperglycemia has been shown to be an independent predictor of 
adverse outcome after acute myocardial Infarction (AMI). Prodromal anglna occurring 
shortly before the onset of AMI has cardioprotective effect by the mechanism of ischemic 
precondltloning. lschemic preconditioning is promoted by opening of mitochondrial K,, 
Predlscharge QRS Score 5.2 * 3.1 4.0 r 2.5 0.01 
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1068A-MP-205 Impact of Known and Newly Diagnosed Diabetes 
Mellitus After a Myocardial Infarction 
Davtd Aauilar, Scott D. Solomon, Lars Kober, Jean-Luclen Rouleau, Hicham Skali, John 
J. McMurray, Gary S. Francis, Marc Hems. Rafael Diaz, Yuri N. Belenkov, Sergei 
Varshavsky, Jeffrey D. Leimberger, Robert M. Califf. Marc A. Pfeffer, Brigham 8 
Women’s Hospital, Boston, MA 
Background Diabetes mellitus (DM) is associated with adverse outcomes in patients 
(pts) presenting with an acute myocardial infarction (AMI). but little IS known of the risk of 
newly diagnosed DM. 
Methods The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial identified 
14,808 pts with an AMI complicated by either clinical or radiologic signs of heart failure 
and/or evidence of left ventricular (LV) systolic dysfunction. Assessment of diabetic sts- 
